糖心传媒

The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances.

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma.

This spring in the U.S., there were widespread delays in elective health care procedures and screenings.

Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology.

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.聽

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.

Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19.

Vanderbilt researchers have identified a new molecular partner 鈥� and potential therapeutic target 鈥� in a signaling axis that drives lung cancer.

A new study from Vanderbilt epidemiologists suggests that it鈥檚 time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women.

A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions.

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) 鈥渄o not support鈥� the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.

Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer鈥檚 Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer鈥檚 disease research. Read More

Jacek Hawiger鈥檚 anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read More

Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior. Read More

Two prototype devices could refine thrombectomy through sensory augmentation.

All-remote collaboration results in free animal susceptibility tool to help prioritize research and closer examination of at-risk species. Read More

Nominations for the 2021 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 11.

Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern.

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of 鈥渃onvalescent plasma鈥� as a treatment for COVID-19.

A small-molecule 鈥渟cavenger鈥� that reduces inflammation and formation of atherosclerotic plaque in blood vessels in mice potentially could lead to a new approach for treating atherosclerosis in humans, according to researchers at Vanderbilt University Medical Center.